Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 119

Similar articles for PubMed (Select 23924928)

1.

Clinical outcome of unprotected left main coronary artery disease in patients with acute myocardial infarction.

Sim DS, Ahn Y, Jeong MH, Kim YJ, Chae SC, Hong TJ, Seong IW, Chae JK, Kim CJ, Cho MC, Seung KB; Korea Acute Myocardial Infarction Registry (KAMIR) Investigators.

Int Heart J. 2013;54(4):185-91.

2.

Clinical outcomes and predictors of unprotected left main stem culprit lesions in patients with acute ST segment elevation myocardial infarction.

Baek JY, Seo SM, Park HJ, Kim PJ, Park MW, Koh YS, Chang KY, Jeong MH, Park SJ, Seung KB.

Catheter Cardiovasc Interv. 2014 Jun 1;83(7):E243-50. doi: 10.1002/ccd.23420. Epub 2013 Nov 30.

PMID:
22105969
3.

Long-term outcomes after stenting versus coronary artery bypass grafting for unprotected left main coronary artery disease: 10-year results of bare-metal stents and 5-year results of drug-eluting stents from the ASAN-MAIN (ASAN Medical Center-Left MAIN Revascularization) Registry.

Park DW, Kim YH, Yun SC, Lee JY, Kim WJ, Kang SJ, Lee SW, Lee CW, Kim JJ, Choo SJ, Chung CH, Lee JW, Park SW, Park SJ.

J Am Coll Cardiol. 2010 Oct 19;56(17):1366-75. doi: 10.1016/j.jacc.2010.03.097.

4.

Impact of diabetes mellitus on patients with unprotected left main coronary artery lesion disease treated with either percutaneous coronary intervention or coronary-artery bypass grafting.

Luo Y, Yu X, Chen F, Du X, He J, Gao Y, Zhang X, Zhang Y, Ren X, Lv S, Ma C.

Coron Artery Dis. 2012 Aug;23(5):322-9. doi: 10.1097/MCA.0b013e3283564961.

PMID:
22750912
5.

Sirolimus-eluting stent treatment for unprotected versus protected left main coronary artery disease in widespread clinical routine: 6-month and 3-year clinical follow-up results from the prospective multicentre German Cypher Registry.

Khattab AA, Hamm CW, Senges J, Toelg R, Geist V, Bonzel T, Kelm M, Levenson B, Neumann FJ, Nienaber CA, Pfannebecker T, Sabin G, Schneider S, Tebbe U, Richardt G; German Cypher Registry.

Heart. 2007 Oct;93(10):1251-5. Erratum in: Heart. 2009 Dec;95(24):2029. Heart. 2010 Mar;96(6):471. Heart. 2010 Dec;96(24):2044.

6.

Sirolimus- vs. paclitaxel-eluting stents for the treatment of unprotected left main coronary artery stenosis: complete 2-year follow-up of a two-center registry.

Park KW, Kang SH, Park KH, Choi DH, Lee HY, Kang HJ, Cho YS, Yeon TJ, Chung WY, Koo BK, Chae IH, Choi DJ, Oh BH, Park YB, Kim HS.

Int J Cardiol. 2011 Aug 18;151(1):89-95. doi: 10.1016/j.ijcard.2010.05.001. Epub 2010 Jun 3.

PMID:
20605240
7.

Multicenter international registry of unprotected left main coronary artery percutaneous coronary intervention with drug-eluting stents in patients with myocardial infarction.

Lee MS, Sillano D, Latib A, Chieffo A, Zoccai GB, Bhatia R, Sheiban I, Colombo A, Tobis J.

Catheter Cardiovasc Interv. 2009 Jan 1;73(1):15-21. doi: 10.1002/ccd.21712.

PMID:
19089930
9.

Multicenter international registry of unprotected left main coronary artery percutaneous coronary intervention with everolimus-eluting stents.

Lee MS, Park KW, Kang SH, Sheiban I, Mahmud E, Thani KB, Cheng R, Cho JH, Jin DK, Gwon HC, Chae IH, Aragon J, Gillis K, Stone GW, Kim HS.

J Invasive Cardiol. 2012 Jul;24(7):316-9.

10.

Comparative long-term efficacy and safety of drug-eluting stent versus coronary artery bypass grafting in ostial left main coronary artery disease: analysis of the MAIN-COMPARE registry.

Lee SW, Kim SH, Kim SO, Han S, Kim YH, Park DW, Kang SJ, Lee CW, Park SW, Park SJ.

Catheter Cardiovasc Interv. 2012 Aug 1;80(2):206-12. doi: 10.1002/ccd.23369. Epub 2012 Jan 10.

PMID:
22234884
11.

Coronary artery bypass grafting versus drug-eluting stent implantation for left main coronary artery disease (from a two-center registry).

Kang SH, Park KH, Choi DJ, Park KW, Chung WY, Lim C, Kim KB, Kim HS.

Am J Cardiol. 2010 Feb 1;105(3):343-51. doi: 10.1016/j.amjcard.2009.09.036.

PMID:
20102946
12.

Comparison of percutaneous coronary intervention (with drug-eluting stents) versus coronary artery bypass grafting in women with severe narrowing of the left main coronary artery (from the Women-Drug-Eluting stent for LefT main coronary Artery disease Registry).

Buchanan GL, Chieffo A, Meliga E, Mehran R, Park SJ, Onuma Y, Capranzano P, Valgimigli M, Narbute I, Makkar RR, Palacios IF, Kim YH, Buszman PP, Chakravarty T, Sheiban I, Naber C, Margey R, Agnihotri A, Marra S, Capodanno D, Allgar V, Leon MB, Moses JW, Fajadet J, Lefevre T, Morice MC, Erglis A, Tamburino C, Alfieri O, Serruys PW, Colombo A.

Am J Cardiol. 2014 Apr 15;113(8):1348-55. doi: 10.1016/j.amjcard.2014.01.409. Epub 2014 Jan 31.

PMID:
24581924
13.

Outcomes according to presentation with versus without cardiogenic shock in patients with left main coronary artery stenosis and acute myocardial infarction.

Kim U, Park JS, Kang SW, Kim YM, Park WJ, Lee SH, Hong GR, Shin DG, Kim YJ, Jeong MH, Chae SC, Hur SH, Song IW, Hong TJ, Chae IH, Cho MC, Jang Y, Yoon J, Seung KB, Park SJ; Korea Acute Myocardial Infarction Registry Investigators.

Am J Cardiol. 2012 Jul 1;110(1):36-9. doi: 10.1016/j.amjcard.2012.02.044. Epub 2012 Apr 3.

PMID:
22481010
14.

Early and long-term results of unprotected left main coronary artery stenosis with paclitaxel-eluting stents: the FRIEND (French multicentre RegIstry for stenting of uNprotecteD LMCA stenosis) registry.

Carrié D, Eltchaninoff H, Lefèvre T, Silvestri M, Brunel P, Fajadet J, Moynagh A, Gilard M, Koning R, Dibie A, Darremont O, Lablanche JM, Blanchard D; FRIEND Investigators.

EuroIntervention. 2011 Oct 30;7(6):680-8. doi: 10.4244/EIJV7I6A110.

15.

Outlook of drug-eluting stent implantation for unprotected left main disease: insights on long-term clinical predictors.

Vecchio S, Chechi T, Vittori G, Biondi Zoccai GG, Lilli A, Spaziani G, Giuliani G, Falchetti E, Margheri M.

J Invasive Cardiol. 2007 Sep;19(9):381-7.

16.

Comparison of clinical outcomes between octogenarians and non-octogenarians with acute myocardial infarction in the drug-eluting stent era: analysis of the Korean Acute Myocardial Infarction Registry.

Yamanaka F, Jeong MH, Saito S, Ahn Y, Chae SC, Hur SH, Hong TJ, Kim YJ, Seong IW, Chae JK, Rhew JY, Chae IH, Cho MC, Bae JH, Rha SW, Kim CJ, Choi D, Jang YS, Yoon J, Chung WS, Cho JG, Seung KB, Park SJ; Korea Acute Myocardial Infarction Registry.

J Cardiol. 2013 Oct;62(4):210-6. doi: 10.1016/j.jjcc.2013.04.003. Epub 2013 May 31.

17.

Readmission rate after coronary artery bypass grafting versus percutaneous coronary intervention for unprotected left main coronary artery narrowing.

Roh JH, Kim YH, Ahn JM, Yun SH, Lee JB, Ge J, Le W, Park GM, Lee JY, Park DW, Kang SJ, Lee SW, Lee CW, Park SW, Park SJ.

Am J Cardiol. 2014 May 15;113(10):1639-46. doi: 10.1016/j.amjcard.2014.02.013. Epub 2014 Mar 1.

PMID:
24666619
18.

Comparison of outcomes of unprotected left main versus multivessel coronary artery interventions.

Agarwal S, Zaman T, Tuzcu EM, Shishehbor M, Lincoff AM, Whitlow PL, Bajzer C, Franco I, Nair R, Raymond R, Ellis SG, Kapadia SR.

Am J Cardiol. 2011 Jul 1;108(1):15-20. doi: 10.1016/j.amjcard.2011.03.002. Epub 2011 Apr 27.

PMID:
21529732
20.

Prognostic impact of using drug-eluting-stents on outcome and strategy in multivessel PCI: data from the Frankfurt MV-PCI registry.

Schwietz T, Ehrlich JR, De Rosa S, Fichtlscherer S, Schächinger V, Baier G, Laskowski R, Zeiher AM, Spyridopoulos I, Lehmann R.

J Cardiol. 2013 Jan;61(1):38-43. doi: 10.1016/j.jjcc.2012.08.008. Epub 2012 Oct 18.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk